<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · AIDS</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to AIDS.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/diseases/aids.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Hepatitis B and C Prevention, Screening, and Diagnostic Services at HIV Treatment Sites: International Epidemiology Databases to Evaluate AIDS.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1097-qai-0000000000003896-a601496f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1097-qai-0000000000003896-a601496f/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>Findings point to gaps in HBV and HCV service availability at HIV treatment sites, particularly rural sites, relevant to efforts to address these infections among people receiving HIV care.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis C</category>
    <category>Hepatitis D</category>
    <category>Hepatitis E</category>
    <category>AIDS</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Seroprevalence, associated factors, and molecular detection of hepatitis B virus co-infection among HIV-positive adults in Okene, Nigeria</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-31989-dsn-v5i8-2066-26506a4f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-31989-dsn-v5i8-2066-26506a4f/</guid>
    <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
    <description>The measured infection frequency indicates a persistent dual-viral burden within this regional healthcare setting, reinforcing the value of systematic diagnostic protocols and immunization initiatives.</description>
    <category>Hepatitis D</category>
    <category>Hepatitis B</category>
    <category>AIDS</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Hearing aids for mild to moderate hearing loss in adults</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd012023-pub3-623f5813/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd012023-pub3-623f5813/</guid>
    <pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate>
    <description>Findings align with routine first-line clinical provision of hearing aids to adults seeking help for hearing difficulties, while signalling ongoing uncertainty around benefits for mental health and cognition.</description>
    <category>AIDS</category>
    <category>Noise-induced hearing loss</category>
    <category>Treatment</category>
    <category>Climate and environment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Pembrolizumab in people with HIV-associated progressive multifocal leukoencephalopathy: a retrospective case series.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1007-s15010-026-02939-z-0c841778/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1007-s15010-026-02939-z-0c841778/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>HIV-associated PML carries high mortality and lacks a specific antiviral therapy, so identifying candidate salvage treatments is relevant to clinical management of this serious complication.</description>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>UGT1A1 gene polymorphisms and their impact on plasma trough concentrations of dolutegravir in Chinese adults with human immunodeficiency virus-1 infection.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1097-cm9-0000000000004204-35a77cfb/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1097-cm9-0000000000004204-35a77cfb/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings identify genetic variants that substantially affect dolutegravir drug levels in Han Chinese populations, which may inform dosing strategies and therapeutic drug monitoring for HIV-1 treatment in this ethnic group.</description>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Do Digital Visual Aids Improve Skin Self-Examination Behaviours? A Systematic Review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1177-10901981261479324-f115e091/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1177-10901981261479324-f115e091/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>Skin self-examination represents a secondary prevention approach for early skin cancer detection. Digital visual aids such as smartphone applications may support broader uptake and maintenance of these examination behaviors.</description>
    <category>AIDS</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>The Level of Knowledge, Attitude, Practice, and Adherence of Obstetricians and Gynecologists Towards the Triple Elimination Program (HIV, Syphilis, Hepatitis B) in Maternal Services at Government and Private Hospitals in Jakarta</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-ijerph23081090-faea2511/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-ijerph23081090-faea2511/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings point to gaps in provider knowledge, attitudes, practice, and adherence related to a program aimed at reducing mother-to-child transmission of HIV, syphilis, and hepatitis B, underscoring the need for targeted improvement efforts in maternal services.</description>
    <category>Hepatitis B</category>
    <category>Syphilis</category>
    <category>AIDS</category>
    <category>Transmission dynamics</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Molecular transmission network and spatial analysis of HIV/AIDS in Hainan, China: a population-based study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fmicb-2026-1907224-b58739ea/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fmicb-2026-1907224-b58739ea/</guid>
    <pubDate>Thu, 20 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings identify the Haikou-Sanya transmission link as a key intervention point and support enhanced regional surveillance and coordinated cross-city prevention strategies in Hainan Province.</description>
    <category>AIDS</category>
    <category>Transmission dynamics</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>CONTEMPORARY CHEST RADIOGRAPHIC MANIFESTATIONS OF PULMONARY TUBERCULOSIS INFECTION WITH HIV/AIDS COINFECTION : A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS AND PRIMARY STUDIES</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-70070-msqq9n43-1141f5e6/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-70070-msqq9n43-1141f5e6/</guid>
    <pubDate>Wed, 19 Aug 2026 00:00:00 GMT</pubDate>
    <description>Conventional imaging protocols frequently miss active infections in immunocompromised cohorts, aligning with the authors&apos; emphasis on laboratory confirmation regardless of scan results.</description>
    <category>Tuberculosis</category>
    <category>AIDS</category>
    <category>Diagnostics</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Siglec-1-targeted nanobodies restrict HIV-1 transmission and infection of dendritic cells</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1128-jvi-00128-26-54366665/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1128-jvi-00128-26-54366665/</guid>
    <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
    <description>The data indicate that interfering with host attachment molecules could theoretically disrupt initial viral dissemination pathways, supporting continued exploration of such mechanisms.</description>
    <category>AIDS</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>RELMα establishes a permissive environment for influenza virus infection through direct effects on lung epithelial cells</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1128-jvi-02225-25-426e78ad/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1128-jvi-02225-25-426e78ad/</guid>
    <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings identify RELMα as a host factor associated with influenza A virus growth in epithelial cells and suggest that epithelial-cell pathways could be investigated as potential therapeutic targets. The supplied evidence is preclinical and does not establish effectiveness, safety, or relevance in humans.</description>
    <category>Influenza</category>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Population-level genome sequencing reveals distinct Mycobacterium tuberculosis intrahost mutational trajectories in simian immunodeficiency virus-coinfected and antiretroviral treated non-human primates</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1128-msystems-00329-26-aa059301/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1128-msystems-00329-26-aa059301/</guid>
    <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
    <description>The abstract frames the work in relation to tuberculosis and HIV coinfection, noting that TB remains a major cause of mortality, particularly among people living with HIV. The study may be relevant to understanding pathogen evolution under immune and treatment-related pressures, but the supplied evidence is from a non-human primate model rather than a clinical intervention study.</description>
    <category>Tuberculosis</category>
    <category>HIV infection</category>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Artificial intelligence and machine learning applications in abdominal tuberculosis diagnosis: A scoping review and translational roadmap</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-35712-aig-123751-6bffb915/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-35712-aig-123751-6bffb915/</guid>
    <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
    <description>Improving detection accuracy for abdominal tuberculosis in resource-constrained environments could mitigate diagnostic delays and support more standardized care delivery pathways.</description>
    <category>Tuberculosis</category>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Antimicrobial resistance</category>
    <category>Diagnostics</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Clinical Epidemiology and Health Systems Determinants of HIV/AIDS Care Outcomes in Port Harcourt Local Government Area, Rivers State, Nigeria</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-9734-ijtdh-2026-v47i81775-8e9c7e9d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-9734-ijtdh-2026-v47i81775-8e9c7e9d/</guid>
    <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
    <description>The 68.3% viral suppression rate falls meaningfully short of the 95-95-95 global target, with facility-type disparities indicating actionable gaps in differentiated service delivery supply chains, mental health integration, and private-sector surveillance reporting that directly affect HIV epidemic control in urban Nigeria.</description>
    <category>AIDS</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>The Application and Impact of Digital Patient Decision Aids in COPD : A Scoping Review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-jocn-70505-b5ee4456/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-jocn-70505-b5ee4456/</guid>
    <pubDate>Sun, 16 Aug 2026 00:00:00 GMT</pubDate>
    <description>The review frames digital patient decision aids as a possible support for shared decision-making in COPD, with outcome evidence centered on decision quality and user experience measures.</description>
    <category>AIDS</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Maternal HIV viral load threshold for guiding extended infant prophylaxis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106779-e698d70a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106779-e698d70a/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings support a simplified risk-stratified approach to initiating extended infant postnatal prophylaxis, potentially enabling more targeted and resource-efficient prevention of mother-to-child HIV transmission during breastfeeding.</description>
    <category>AIDS</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>COVID-19 vaccination among people with HIV in Uganda: lessons from a high-risk group with high vaccine uptake for the next pandemic</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128912-61c4c107/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128912-61c4c107/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>Sustaining elevated protection levels in this clinical subgroup requires targeted communication strategies that address safety perceptions and counteract inaccurate health information.</description>
    <category>COVID-19</category>
    <category>AIDS</category>
    <category>Vaccination</category>
    <category>Vaccine safety</category>
    <category>Treatment</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Antiviral Effect, Safety, and Tolerability of Oral VH4011499, a New Human Immunodeficiency Virus Capsid Inhibitor: Proof-of-Concept Trial</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciag452-9a601253/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciag452-9a601253/</guid>
    <pubDate>Wed, 29 Jul 2026 00:00:00 GMT</pubDate>
    <description>The abstract identifies a need for innovative HIV-1 therapies, particularly those permitting infrequent dosing, and states that these results support further development of VH4011499 as a component of a complete long-acting treatment regimen.</description>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>An ATPγS recycling strategy for practical biocatalytic thiophosphorylation</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41586-026-10895-9-dcaa38b7/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41586-026-10895-9-dcaa38b7/</guid>
    <pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate>
    <description>The authors position thiophosphates as metabolically stable motifs used in therapeutic modalities such as antisense oligonucleotides and cyclic dinucleotide analogues, suggesting the strategy could support drug development efforts, though no direct clinical or population-level outcomes are reported.</description>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Vaccination elicits HIV broadly neutralizing antibodies in primates</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41586-026-10837-5-550acf2d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41586-026-10837-5-550acf2d/</guid>
    <pubDate>Tue, 30 Jun 2026 00:00:00 GMT</pubDate>
    <description>The findings provide proof of principle that germline-targeting vaccines can reproducibly elicit predetermined classes of broadly neutralizing antibodies to specific epitopes, supporting continued development of this approach for HIV vaccine design. HIV antigenic diversity has historically impeded broadly protective vaccine development.</description>
    <category>AIDS</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1126-science-aec6396-584544aa/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1126-science-aec6396-584544aa/</guid>
    <pubDate>Thu, 18 Jun 2026 00:00:00 GMT</pubDate>
    <description>The findings address a major barrier in HIV vaccine development by demonstrating a reproducible method for eliciting broadly neutralizing antibodies in an animal model. The identified envelope-antibody coevolution pathway provides a molecular template that could inform rational HIV vaccine design strategies.</description>
    <category>AIDS</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>High frequency of HIV-1 drug resistance among individuals with persistent low-level viremia during first-line antiretroviral therapy in Uganda</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13774-w-8756edff/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13774-w-8756edff/</guid>
    <pubDate>Tue, 16 Jun 2026 00:00:00 GMT</pubDate>
    <description>The findings suggest that drug resistance genotyping should be considered for individuals on first-line therapy with detectable persistent low-level viremia. Targeted interventions for youth may improve HIV control outcomes.</description>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Efficacy and safety of TDF+3TC + EFV‑centric antiretroviral regimens for HIV/HBV co-infection: a systematic review and network meta‑analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13806-5-fad0a9c9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13806-5-fad0a9c9/</guid>
    <pubDate>Sat, 13 Jun 2026 00:00:00 GMT</pubDate>
    <description>The review provides comparative treatment evidence concerning virologic outcomes, CD4+ lymphocyte counts, and reported safety outcomes in people with HIV/HBV co-infection. Its findings may support editorial understanding of the treatment-evidence literature, but the supplied abstract does not establish effectiveness in a broader population or provide implementation, access, or outcome data outside the included trials.</description>
    <category>Hepatitis D</category>
    <category>Hepatitis B</category>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Complete remission of HIV-associated glomerular disease with tacrolimus, followed by late-onset Kaposi sarcoma: A report of two cases</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108430-684242f1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108430-684242f1/</guid>
    <pubDate>Wed, 01 Apr 2026 00:00:00 GMT</pubDate>
    <description>The cases identify a reported long-term safety concern for immunosuppressive treatment in people living with HIV who have glomerular disease. They may be relevant to editorial consideration of treatment-related adverse-event evidence, but the findings are limited to two cases.</description>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection in People With HIV</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciaf635-5be79539/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciaf635-5be79539/</guid>
    <pubDate>Wed, 19 Nov 2025 00:00:00 GMT</pubDate>
    <description>These quantitative projections help guide institutional planning for post-viral eradication monitoring programs, especially as therapeutic access widens across different regions.</description>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Clinical Recommendation for the Use of Injectable Lenacapavir as HIV Preexposure Prophylaxis — United States, 2025</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7435a1-0033bc2a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7435a1-0033bc2a/</guid>
    <pubDate>Thu, 18 Sep 2025 00:00:00 GMT</pubDate>
    <description>With approximately 39,000 new HIV diagnoses annually in the United States and suboptimal adherence to existing oral and injectable PrEP regimens, a strongly recommended 6-month injectable option may improve adherence and strengthen HIV prevention efforts.</description>
    <category>AIDS</category>
    <category>HIV infection</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Transmitted HIV-1 Drug Resistance Among Newly Diagnosed Individuals in 31 Provincial-Level Administrative Divisions in China in 2023: A Cross-sectional Survey</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciaf159-81fb5384/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciaf159-81fb5384/</guid>
    <pubDate>Tue, 29 Apr 2025 00:00:00 GMT</pubDate>
    <description>TDR prevalence exceeding 10%, including &gt;5% to efavirenz/nevirapine, suggests a need for ongoing surveillance and consideration of regimen selection in newly diagnosed populations in China.</description>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>HIV, malnutrition, and noncommunicable disease epidemics among tuberculosis-affected households in east and southern Africa: A cross-sectional analysis of the ERASE-TB cohort</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1004452-283a778b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1004452-283a778b/</guid>
    <pubDate>Mon, 16 Sep 2024 00:00:00 GMT</pubDate>
    <description>The paper presents TB screening as a possible point to find and address other health problems in affected households. It frames integrated approaches as a way to identify people at higher risk and connect them with preventive or treatment services.</description>
    <category>Tuberculosis</category>
    <category>AIDS</category>
    <category>Climate and environment</category>
    <category>Treatment</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Epidemiological features and temporal trends of the co-infection between HIV and tuberculosis, 1990–2021: findings from the Global Burden of Disease Study 2021</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s40249-024-01230-3-5696923f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s40249-024-01230-3-5696923f/</guid>
    <pubDate>Fri, 16 Aug 2024 00:00:00 GMT</pubDate>
    <description>HIV-TB co-infection represents a major global public health challenge. The findings suggest that improved diagnostic and treatment strategies, strengthened healthcare infrastructure, increased access to quality care, and enhanced public health education are needed to address this co-infection.</description>
    <category>Tuberculosis</category>
    <category>AIDS</category>
    <category>Multidrug-resistant tuberculosis</category>
    <category>Antimicrobial resistance</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Differences between males and females in infectious diseases notifications in the EU/EEA, 2012 to 2021</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-33-2300655-91c183b8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-33-2300655-91c183b8/</guid>
    <pubDate>Thu, 15 Aug 2024 00:00:00 GMT</pubDate>
    <description>The paper is relevant to surveillance review because it summarizes sex-pattern differences in reported infectious diseases across the EU/EEA. It also notes that behavior may contribute for some infections and that screening practices may help explain country differences, but these are presented as interpretations rather than confirmed effects.</description>
    <category>COVID-19</category>
    <category>Malaria</category>
    <category>Chlamydia trachomatis infection</category>
    <category>Hepatitis B</category>
    <category>Listeriosis</category>
    <category>Acute hepatitis B</category>
    <category>Pertussis</category>
    <category>AIDS</category>
    <category>Campylobacteriosis</category>
    <category>One Health</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Impact of COVID-19 on the neglected tropical diseases: a scoping review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s40249-024-01223-2-9ee059af/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s40249-024-01223-2-9ee059af/</guid>
    <pubDate>Mon, 29 Jul 2024 00:00:00 GMT</pubDate>
    <description>The pandemic diverted attention and funding from NTD research and development, straining weak healthcare systems in LMICs and creating delays that will have long-reaching consequences. Without significant recovery investment, NTD roadmap targets and milestones are unlikely to be met, highlighting the need for global cooperation and renewed investment.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Leprosy</category>
    <category>Rabies</category>
    <category>Schistosomiasis</category>
    <category>Malaria</category>
    <category>Cysticercosis</category>
    <category>Trachoma</category>
    <category>AIDS</category>
    <category>Taeniasis</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Independent clinic-based evaluation of dual POCTs for screening for HIV and syphilis in men who have sex with men in Italy, Malta, Peru, and the United Kingdom</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-024-09019-3-5bf76d5e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-024-09019-3-5bf76d5e/</guid>
    <pubDate>Thu, 29 Feb 2024 00:00:00 GMT</pubDate>
    <description>Dual point-of-care tests could serve as a cost-effective, patient-friendly, and provider-friendly alternative to conventional testing in clinical and field settings, particularly in resource-limited environments where validated screening tools may help reduce HIV and syphilis incidence.</description>
    <category>Syphilis</category>
    <category>AIDS</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Meta-analysis</category>
  </item>
  <item>
    <title>The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1004325-c81d8d57/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1004325-c81d8d57/</guid>
    <pubDate>Fri, 12 Jan 2024 00:00:00 GMT</pubDate>
    <description>The forecasted rise in comorbidity and multimorbidity among people aging with HIV has implications for clinical workforce preparedness, subspecialty care linkages, and resource allocation. Clinicians will need to remain current on evolving comorbidity-specific guidelines, and policymakers must support extended clinical capacity to meet complex healthcare needs.</description>
    <category>AIDS</category>
    <category>Climate and environment</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa2215201-466804dd/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa2215201-466804dd/</guid>
    <pubDate>Thu, 29 Jun 2023 00:00:00 GMT</pubDate>
    <description>The findings support the usefulness of JYNNEOS vaccination against mpox disease and suggest greater protection with completion of the two-dose series, relevant to U.S. outbreak control among at-risk adults.</description>
    <category>Monkeypox</category>
    <category>Smallpox</category>
    <category>HIV infection</category>
    <category>AIDS</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Outbreak investigation</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Molecular genetics and epidemiological characteristics of HIV-1 epidemic strains in various sexual risk behaviour groups in developed Eastern China, 2017–2020</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2022-2119167-c0ea35e6/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2022-2119167-c0ea35e6/</guid>
    <pubDate>Tue, 27 Sep 2022 00:00:00 GMT</pubDate>
    <description>The findings identify CRF07_BC-infected individuals as key epidemic drivers and emphasize the need for targeted interventions on key clusters and individuals to block continued HIV-1 transmission across sexual risk groups.</description>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Transmission dynamics</category>
    <category>Genomic epidemiology</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>HIV-1 pretreatment drug resistance and genetic transmission network in the southwest border region of China</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-022-07734-3-0d428136/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-022-07734-3-0d428136/</guid>
    <pubDate>Mon, 19 Sep 2022 00:00:00 GMT</pubDate>
    <description>The authors frame pretreatment resistance, especially NNRTI resistance, as relevant to antiretroviral treatment planning and ongoing surveillance in this border prefecture. The article is also indexed under surveillance, transmission dynamics, and treatment topics, which supports its public-health and epidemiologic context.</description>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Transmission dynamics</category>
    <category>Surveillance</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Characterization of HIV-1 molecular epidemiology and transmitted drug-resistance in newly diagnosed HIV-infected patients in Sichuan, China</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-022-07576-z-0025e048/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-022-07576-z-0025e048/</guid>
    <pubDate>Thu, 07 Jul 2022 00:00:00 GMT</pubDate>
    <description>Tracking pretreatment resistance patterns aids in evaluating current antiretroviral protocols and highlights the need for expanded behavioral outreach targeting underrepresented demographic segments.</description>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Genomic epidemiology</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-21-00570-5-d82ec9d9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-21-00570-5-d82ec9d9/</guid>
    <pubDate>Thu, 01 Apr 2021 00:00:00 GMT</pubDate>
    <description>Current strategies may be insufficient to eliminate mother-to-child HIV transmission through breastfeeding unless universally applied. Urgent evaluation and implementation of additional preventive biomedical strategies is needed in high burden settings, including pre-exposure prophylaxis for at-risk breastfeeding women, postnatal reinforcement with maternal retesting and infant prophylaxis, and immunoprophylaxis with vaccines or broadly neutralizing antibodies.</description>
    <category>AIDS</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Using molecular transmission networks to understand the epidemic characteristics of HIV-1 CRF08_BC across China</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2021-1899056-4568b522/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2021-1899056-4568b522/</guid>
    <pubDate>Mon, 22 Mar 2021 00:00:00 GMT</pubDate>
    <description>Identifying concentrated transmission pockets enables authorities to direct preventive resources toward high-risk demographics and geographic zones.</description>
    <category>AIDS</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Epidemiological profile and molecular genetic characterization of HIV-1 among female sex workers and elderly male clients in Guangxi, China</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2021-1888659-cdc361f6/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2021-1888659-cdc361f6/</guid>
    <pubDate>Wed, 03 Mar 2021 00:00:00 GMT</pubDate>
    <description>The findings provide contextual information about HIV-1 subtype distribution, genetic linkage patterns, and geographic clustering among the studied groups in Guangxi. They may support interpretation of transmission-network research in this setting, but the supplied evidence does not establish effects of interventions or broader population-level trends.</description>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Transmission dynamics</category>
    <category>Genomic epidemiology</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Global burden of active smoking among people living with HIV on antiretroviral therapy: a systematic review and meta-analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s40249-021-00799-3-32bc8038/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s40249-021-00799-3-32bc8038/</guid>
    <pubDate>Fri, 12 Feb 2021 00:00:00 GMT</pubDate>
    <description>The authors highlight a high prevalence of active smoking in PLHIV on ART and suggest that healthcare providers and policy makers consider tobacco harm reduction strategies within HIV care, with particular attention to sub-Saharan Africa.</description>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2020-1713707-ad9b1004/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2020-1713707-ad9b1004/</guid>
    <pubDate>Mon, 27 Jan 2020 00:00:00 GMT</pubDate>
    <description>Given the limitations of current antiretroviral therapy and absence of a successful vaccine, broadly neutralizing antibodies represent a novel immunotherapy approach for HIV-1 prevention and treatment.</description>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus–Exposed, Uninfected Infants</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciz1186-dccdce91/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciz1186-dccdce91/</guid>
    <pubDate>Fri, 13 Dec 2019 00:00:00 GMT</pubDate>
    <description>Rising antibiotic resistance poses particular concern in low- and middle-income countries with higher perinatal HIV exposure rates and wider cotrimoxazole prophylaxis use. Findings may inform revisions to current infant prophylaxis guidelines.</description>
    <category>AIDS</category>
    <category>Antimicrobial resistance</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Prevalence, predictors, and management of advanced HIV disease among individuals initiating ART in Senegal, West Africa</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-019-3826-5-6e1ce371/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-019-3826-5-6e1ce371/</guid>
    <pubDate>Fri, 15 Mar 2019 00:00:00 GMT</pubDate>
    <description>The high prevalence of advanced HIV disease at ART initiation and numerous missed opportunities for prevention and early diagnosis suggest substantial gaps in implementing WHO guidelines, indicating potential for preventable HIV-associated morbidity and mortality in Senegal.</description>
    <category>AIDS</category>
    <category>Tuberculosis</category>
    <category>Health policy</category>
    <category>Treatment</category>
    <category>Diagnostics</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm6725a5-6bdcf44b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm6725a5-6bdcf44b/</guid>
    <pubDate>Fri, 29 Jun 2018 00:00:00 GMT</pubDate>
    <description>Broadening access to highly adherent preventive therapies supports national objectives to interrupt pathogen transmission and reduce disease burden across varied demographic groups.</description>
    <category>Tuberculosis</category>
    <category>HIV infection</category>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-civ609-6409334c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-civ609-6409334c/</guid>
    <pubDate>Fri, 25 Sep 2015 00:00:00 GMT</pubDate>
    <description>The article characterizes tuberculosis as a continuing global emergency and identifies early rapid diagnosis, shorter treatment, improved outcomes, and prevention as urgent areas for innovation and sustained political and funding commitment.</description>
    <category>Tuberculosis</category>
    <category>AIDS</category>
    <category>Antimicrobial resistance</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciu617-bb6322ca/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciu617-bb6322ca/</guid>
    <pubDate>Wed, 17 Sep 2014 00:00:00 GMT</pubDate>
    <description>The guideline addresses a clinically relevant intersection of HIV and chronic kidney disease and frames clinical decision-making for affected patients.</description>
    <category>AIDS</category>
    <category>Health policy</category>
    <category>Treatment</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Modeling Scenarios for the End of AIDS</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciu339-0b2b0bed/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciu339-0b2b0bed/</guid>
    <pubDate>Tue, 01 Jul 2014 00:00:00 GMT</pubDate>
    <description>The article is relevant to HIV/AIDS control because it addresses transmission dynamics, prevention strategy, treatment coverage, and financing of the response in a setting of continuing global burden.</description>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Assessing the impact of TB/HIV services integration on TB treatment outcomes and their relevance in TB/HIV monitoring in Ghana</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-2049-9957-1-13-04dcec00/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-2049-9957-1-13-04dcec00/</guid>
    <pubDate>Mon, 24 Dec 2012 00:00:00 GMT</pubDate>
    <description>The findings address a major public health challenge in Ghana where HIV substantially affects TB control. The study informs policy on integrating TB and HIV services to reduce fragmentation, improve access, and enhance quality of care.</description>
    <category>Tuberculosis</category>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Climate and environment</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Eliminating mother-to-child HIV transmission in South Africa</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2471-blt-12-106807-e1a8b381/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2471-blt-12-106807-e1a8b381/</guid>
    <pubDate>Mon, 19 Nov 2012 00:00:00 GMT</pubDate>
    <description>Demonstrates how coordinated policy adoption and infrastructure expansion can improve preventive care delivery and lower disease burden in high-prevalence regions.</description>
    <category>AIDS</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Climate and environment</category>
    <category>Treatment</category>
    <category>Guideline</category>
  </item>
</channel>
</rss>
